Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advantage of Clonidine With Morphine In Patient Controlled Analgesia Pump for the Treatment of Vaso-occlusive Crisis in Sickle Cell Disease Patients

NCT05848531 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Saint Pierre as lead sponsor.

NCT NCT05848531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05848531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advantage of Clonidine With Morphine In Patient Controlled Analgesia Pump for the Treatment of Vaso-occlusive Crisis in Sickle Cell Disease Patients
Lead sponsor
Centre Hospitalier Universitaire Saint Pierre
Phase
Phase 4
Overall status
Unknown status
Start date
April 25, 2023
Completion date
February 28, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease, vaso-occlusive pain episode in sickle cell disease